HomeBreaking NewsDRI Searches Cipla Office, Bhiwandi Depot Over Imported Drug

DRI Searches Cipla Office, Bhiwandi Depot Over Imported Drug

The Directorate of Revenue Intelligence’s Mumbai zonal unit searched Cipla’s office in Vikhroli and its depot in Bhiwandi, Thane, over the classification or exemption of an imported pharmaceutical finished product, the company said in a regulatory filing on November 17.

Cipla said the search proceedings were conducted on Monday under Section 105 of the Customs Act, 1962. The action covers two facilities in the Mumbai metropolitan region: the company’s office in Vikhroli and its distribution depot in Bhiwandi.

According to the filing, the matter relates to the “classification or exemption of an imported pharmaceutical finished product”. The filing did not identify the product or provide further details about the specific customs classification or exemption under examination.

Cipla said it had extended full cooperation and assistance to the authorities during the proceedings. The company also stated that the search had no material impact on its financials, operations or other activities.

The action places attention on the regulatory processes governing imported pharmaceutical products as they move through corporate and distribution facilities. Bhiwandi is a major warehousing and logistics centre in the Mumbai region, while Vikhroli is home to offices and commercial facilities serving the metropolitan economy.

Cipla’s disclosure was made under Regulation 30 of the Securities and Exchange Board of India’s Listing Regulations, which requires listed companies to report material events and developments. The company’s shares were trading at Rs 1,390.70 on the BSE, down 0.24 per cent when the report was filed.

The filing did not indicate any disruption to Cipla’s operations or provide a timeline for further proceedings. The DRI’s search proceedings and any subsequent regulatory action will determine the next formal development in the matter.


RELATED ARTICLES

Most Popular

Latest News